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Xu-Yong Lin1,2, Yan Wang1,2, Juan-Han Yu1,2, Yang Liu1,2, Liang Wang1,2, Qing-Chang Li1,2 and En-Hua Wang1,2*Abstract: Sclerosing rhabdomyosarcoma (SRMS) is exceedingly rare, and may cause a great diagnostic confusion.
Histologically, it is characterized by abundant extracellular hyalinized matrix mimicking primitive chondroid or
osteoid tissue. So, it may be easily misdiagnosed as chondrosarcoma, osteosarcoma, angiosarcoma and so on.
Herein, we report a case of SRMS occurring in the masseter muscle in a 40-year-old male. The tumor showed a
diverse histological pattern. The tumor cells were arranged into nests, cords, pseudovascular, adenoid, microalveoli
and even single-file arrays. Immunostaining showed that the tumor was positive for the Vimentin, Desmin and
MyoD1, and was negative for CK, P63, NSE, CD45, CD30, S-100, CD99, Myoglobin, CD68, CD34, CD31, and α–SMA.
Based on the morphological finding and immunostaining, it was diagnosed as a SRMS. In addition, focally, our case
also displayed a cribriform pattern resembling adenoid cystic carcinoma. This may represent a new histological
feature which can broaden the histological spectrum of this tumor and also may lead to diagnostic confusion.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1615846455818924
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Rhabdomyosarcoma (RMS) is relatively uncommon in
all soft tissue tumors, and also rare in adults older than
45 years [1]. However, it is the most common soft tissue
sarcoma in children. In the current WHO soft tissue
tumor classification, RMS is divided into three groups:
embryonal (ERMS), alveolar (ARMS) and pleomorphic
(PRMS) [1]. The sclerosing rhabdomyosarcoma (SRMS)
is an exceedingly rare variant first described by Mentzel
and Katenkamp [2], which is still controversial. So far,
there are less than 40 reported cases (the present case is
not included) in English literatures [3-17]. Because of its
rarity, it is still unclear whether SRMS belongs to an un-
usual subtype of ARMS or ERMS, or even a new variant
of RMS [6,8,13,17].
Microscopically, SRMS has a characteristic constella-
tion of features. The neoplastic cells can be arranged
into lobules, small nests, microalveoli and even single-
file arrays in an abundant hyalinized, eosinophilic to
basophilic matrix that closely resembles primitive* Correspondence: wangeh@hotmail.com
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reproduction in any medium, provided the orosteoid or chondroid material [18]. So, it is easily mis-
diagnosed, if one unfamiliar with the histological
spectrum of this entity. Herein, we report a case of scler-
osing rhabdomyosarcoma arising in masseter muscle in
a 40-year-old male. In addition to the above histological
features, the cribriform pattern resembling adenoid cys-
tic carcinoma could also be seen in focal areas. This may
represent a new histological feature, which can cause a
diagnostic confusion.Case presentation
A 40-year-old male presented with a painless swelling in
the right parotid gland region. The patient reported the
swelling was approximately 1 cm in size 3 months ago,
and increased rapidly in size recently. Physical examin-
ation revealed a 5-cm subcutaneous mass which felt firm
and adhered to the adjacent tissue. Ultrasonography
revealed a low echo mass measuring 57.1×26.3 mm in
the subcutaneous tissue of the right parotid gland area,
the mass was relatively well circumscribed. Magnetic
resonance imaging revealed an oval mass about 5.2×
3.1 cm with long T1 and long T2 signal in the right
lower masseter (Figure 1). The display of masseter
muscle was not clear. The parotid gland and the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Magnetic resonance imaging revealing the tumor. A and B, Magnetic resonance imaging revealed an oval mass about 5.2× 3.1 cm
in the right lower masseter. The tumor was relatively well circumscribed.
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the tumor. Then the tumor was excised and was sent for
pathological examination.
Methods
The submitted specimens were fixed with 10% neutral-
buffered formalin and embedded in paraffin blocks. Tis-
sue blocks were cut into 4-μm slides, deparaffinized in
xylene, rehydrated with graded alcohols, and immunos-
tained with the following antibodies: Vimentin, Desmin,
MyoD1, CK, P63, NSE, CD45, CD30, S-100, CD99,
Myoglobin, CD68, CD34, CD31, α–SMA and Ki-67. Sec-
tions were stained with a streptavidin-peroxidase system
(KIT-9720, Ultrasensitive TM S-P, MaiXin, China). The
chromogen used was diaminobenzidine tetrahydrochlor-
ide substrate (DAB kit, MaiXin, China), and sections
were slightly counterstained with hematoxylin, dehy-
drated and mounted.
This study was prospectively performed and approved
by the institutional Ethics Committees of China Medical
University and conducted in accordance with the ethical
guidelines of the Declaration of Helsinki.
Results
Grossly, the resected tumor measured 5.1×3.0×2.8 cm,
and was relatively well circumscribed, the cut surface
showed consistently firm and grey-white in colour. His-
tologically, the tumor displayed a characteristic constel-
lation of features with moderate cellularity, and was
predominantly made up of small round and polygonal
cells with a small amount of plasma, coarse nuclear
chromatin and inconspicuous nucleoli. Focally, the
tumor cells showed intracytoplasmic vacuoles resem-
bling chondrocytes. The tumor cells were arranged in a
diverse pattern, including nests, cords, pseudovascular,adenoid, microalveoli and even single-file arrays. More-
over, a cribriform pattern resembling adenoid cystic car-
cinoma could also be seen in focal areas. The mitotic
rate of the tumor cells is very high, and atypical mitosis
could be seen easily. At the margin, the tumor infiltrated
the normal skeletal muscle tissues (Figure 2). In the ma-
jority of the whole tumor, the stroma consisted of abun-
dant myxoid or basophilic matrix closely mimicking
primitive chondroid materials, and in focal areas, hyali-
nized eosinophilic keloid-like collagen matrix mimicking
primitive osteoid tissues could also be seen. Occasion-
ally, scattered cells could be seen in the extensive myx-
oid stroma.
Immunostaining showed that the tumor was strongly
positive for Vimentin, Desmin and MyoD1, and was
negative for CK, P63, NSE, CD45, CD30, S-100, CD99,
Myoglobin, CD68, CD34, CD31, α–SMA. Ki67 was
expressed in more than 60% of all tumor cells (Figure 3).
According to the morphological and immunohistochem-
ical findings, the tumor was diagnosed as a SRMS.
Discussion
SRMS is an unusual variant of RMS that was first
described in 2000 by Mentzel and Katenkamp [2]. They
described three cases of RMS in adult patients,
characterized by prominent hyaline sclerosis and a pseu-
dovascular growth pattern, and termed sclerosing, pseu-
dovascular rhabdomyosarcoma. In 2002, Folpe et al. also
described four cases of an unusual hyalinizing, matrix-
rich variant of RMS. They named it as sclerosing
rhabdomyosarcoma [3]. Subsequently, there have been
several additional reports of SRMS. However, so far,
there was still less than 40 reported cases (the present
case is not included) in English literatures [4-17]. Be-
cause of its scarcity, it is still debated whether SRMS is a
Figure 2 Morphological changes of the tumor. A, The tumor infiltrated the normal skeletal muscle tissues (red arrow). B, Focally, the tumor
cells showed a pattern closely resembling adenoid cystic carcinoma. C, The cells were arranged into cords or single-file arrays paralleled with
each other. D, The cells surrounded the thick-walled blood vessel, and showed a characteristic constellation of features. E, Primitive chondroid
matrix and cells with intracytoplasmic vacuole could be seen in focal areas. F, The tumor cells showed adenoid or microalveoli pattern in
abundant basophilic matrix, and an atypical mitosis could be seen (green arrow). G, Occasionally, hyalinized, eosinophilic keloid-like collagen
(black arrow) could be seen. H, Pseudovascular lumens were filled with numerous red cells. I, In extensive myxoid stroma, scarcely scattered cells
could be seen.
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Although SRMS shares some overlapping features with
both ERMS and ARMS, it lacks 11p15.5 anomaly fre-
quently observed in ERMS [13,16], and also lacks
FOXO1-PAX3 or -PAX7 fusion transcripts associated
with ARMS [8]. According to Julie et al., among the 39
reported cases, SRMS can arise in a broad age ranged
from 0.3 to 79 years with an average age at 27. The most
commonly involved sites (including the present case) are
the extremities (19/40) and head and neck (16/40) [17].
Histologically, SRMS has a characteristic constellation
of features and is characterized by hyalinized, eosino-
philic to basophilic matrix [18]. The tumor usually con-
sisted of small round and polygonal cells with a small
amount of plasma, coarse nuclear chromatin and incon-
spicuous nucleoli. The mitotic rate is very high. Thetumor cells were arranged in a diverse pattern, including
nests, cords, pseudovascular, adenoid, microalveoli and
even single-file arrays. In our case, in a few foci, the
tumor cells also displayed a cribiform pattern, which
might lead to a diagnostic confusion with adenoid cystic
carcinoma. To our knowledge, this is the first reported
case which may display the feature resembling adenoid
cystic carcinoma.
Immunohistochemically, SRMS is usually strongly
positive for Vimentin, Desmin and MyoD1, and weakly,
focally positive for Moygenin suggesting its skeletal
muscle differentiation, but negative for CK, S-100,
CD34, and CD31 [2,3,8,11]. Some cases can also show
positive expression of CD99, SMA and CD56 [3,12,17].
In contrast, Myoglobin, a differentiated striated muscle
marker was usually not expressed in SRMS, indicating
Figure 3 Immunohistochemical staining for CK, α–SMA, Myoglobin, MyoD1, Desmin and Ki-67 in the tumor. A, The tumor cells were
negative for CK. B, α–SMA was expressed in the wall of blood vessel, but not expressed in tumor cells. C, Myoglobin immunostaining highlighted
the entrapped striated muscle cells, but was not positive in tumor cells. D, The tumor cells showed a diffuse positive immunostaining for MyoD1.
E, The majority of the cells were positive for Desmin. F, Ki-67 index was approximate 60%.
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immunohistochemical results are generally similar to
those reported previously. The tumor cells were strongly
positive for Vimentin, Desmin and MyoD1.
The differential diagnosis of SRMS includes osteosar-
coma, extraskeletal myxoid chondrosarcoma, mesenchy-
mal chondrosarcoma, sclerosing epithelioid fibrosarcoma,
angiosarcoma, parachordoma and even metastatic carcin-
oma. The typical osteosarcoma is characterized by the
presence of matrix calcification, osteoclasts. Extraskeletal
myxoid chondrosarcoma typically forms a well circum-
scribed, multilobulated architecture separated by incom-
plete fibrous septa. It is composed of round or slightly
elongated cells of uniform shape and size usually arranged
in short anastomosing strands or cords in myxoid matrix[20]. Mesenchymal chondrosarcoma is characterized by
distinct undifferentiated tumor cells admixed with well
differentiated cartilagenous components [21]. Sclerosing
epithelioid fibrosarcoma is composed of epitheloid cells
arranged in nests and cords and deposited in a densely
hyalinized collagenous matrix. However, in almost all
cases the tumor also shows foci of spindle-shaped sarcoma
similar to conventional fibrosarcoma. SRMS focally may
also form anastomosing vascular and gland-like spaces
mimicing angiosarcoma, but angiosarcoma lacks charac-
teristic hyalinizing matrix of SRMS [22-25]. Parachordoma
is typically lobulated and contains nests of vacuolated cells
deposited in a myxoid matrix, resembling the physaliphor-
ous cells of chordoma. It usually expresses S-100 protein
and CK simultaneously [20]. Moreover, the positive
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of CK can also rule out the possibility of metastatic
carcinoma.
In addition, in our case, the tumor cells focally dis-
played the cribriform pattern closely mimicking adenoid
cystic carcinoma. So, the differential diagnosis may also
include the latter. Adenoid cystic carcinoma consists of
basaloid cells with round to oval or angulated hyper-
chromatic nuclei in eosinophilic, hyalinized, or collage-
nous stroma. Immunohistochemically, adenoid cystic
carcinoma can express epithelial cell marker CK, EMA
and myoepithelial cell marker P63, S-100 or SMA, by
which it can be differentiated from SRMS.
Conclusion
Because of the rarity, SRMS is misdiagnosed easily, espe-
cially if one unfamiliar with this entity. It shows a variable
histological pattern. The tumor cells can be arranged into
nests, cords, pseudovascular, adenoid, microalveoli and
even single-file arrays. In addition, our case also displayed
a cribriform pattern resembling adenoid cystic carcinoma
in focal areas. To avoid the misdiagnosis, careful attention
must be paid to its special histological features.
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